Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma

Serological Biomarkers of Hepatocellular Carcinoma in Egyptian Patients

(2013) Sarmad F. El-Tayeh et al.   DISEASE MARKERS

Human hepatocyte carcinogenesis

(2013) HIDENORI SHIRAHA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis

(2012) Habtom W. Ressom et al.   ANALYTICA CHIMICA ACTA

The Significance of MMP-9 Over MMP-2 in HCC Invasiveness and Recurrence of Hepatocellular Carcinoma After Curative Resection

(2011) Rongxin Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinoma

(2011) Florian R. Thieringer et al.   MOLECULAR CARCINOGENESIS

Hepatocellular Carcinoma

(2011) Hashem B. El-Serag   NEW ENGLAND JOURNAL OF MEDICINE

Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients

(2010) Gamal Badra et al.   ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

A three-dimensional cell biology model of human hepatocellular carcinoma in vitro

(2010) Jianhua Tang et al.   TUMOR BIOLOGY

Present and future possibilities for early diagnosis of hepatocellular carcinoma

(2010) Piotr Stefaniuk   WORLD JOURNAL OF GASTROENTEROLOGY

Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis

(2009) Pu Yang et al.   HEPATOLOGY RESEARCH

Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma

(2008) Yasunori Matsuda et al.   HEPATOLOGY RESEARCH

Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model

(2008) Hai-Ying Liu et al.   WORLD JOURNAL OF GASTROENTEROLOGY